Soypeptide Lunasin in Cytokine Immunotherapy for Lymphoma
This 2014 study investigates the synergistic effects of the soybean-derived peptide lunasin combined with cytokines IL-2 and IL-12 on natural killer (NK) cells in the context of lymphoma immunotherapy. Lunasin enhances NK cell activation, increasing the expression of IFNγ and granzyme B, leading to improved cytotoxicity against lymphoma cells. Notably,
June 26, 2025
No Comments